TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $13,770,000 | -16.5% | 500,000 | -50.0% | 0.28% | -4.1% |
| Q1 2021 | $16,490,000 | -25.4% | 1,000,000 | -16.7% | 0.29% | -38.7% |
| Q4 2020 | $22,116,000 | +16.1% | 1,200,000 | -14.3% | 0.48% | +2.6% |
| Q3 2020 | $19,054,000 | -33.5% | 1,400,000 | -12.5% | 0.46% | -42.3% |
| Q2 2020 | $28,672,000 | +379.3% | 1,600,000 | +166.7% | 0.80% | +217.0% |
| Q1 2020 | $5,982,000 | +13.1% | 600,000 | -7.7% | 0.25% | +24.0% |
| Q4 2019 | $5,291,000 | -28.8% | 650,000 | -13.3% | 0.20% | -31.5% |
| Q3 2019 | $7,433,000 | -21.5% | 750,000 | 0.0% | 0.30% | -22.2% |
| Q2 2019 | $9,473,000 | +54.9% | 750,000 | +25.0% | 0.38% | +53.2% |
| Q1 2019 | $6,114,000 | +35.9% | 600,000 | 0.0% | 0.25% | +49.7% |
| Q4 2018 | $4,500,000 | -25.0% | 600,000 | 0.0% | 0.17% | +7.1% |
| Q3 2018 | $6,000,000 | -5.1% | 600,000 | +20.0% | 0.16% | +16.4% |
| Q2 2018 | $6,325,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |